The "RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's offering. This report describes and explains the ...

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Fragment-based screening (FBS) by NMR has become a key tool in the pharmaceutical industry for identifying new ligands that bind to specific biological targets. NMR also plays a crucial role in ...

SEATTLE, April 15, 2025 /PRNewswire/ -- Wayfinder Biosciences, a biotechnology company targeting RNA with small molecules, announced today a collaboration with Daiichi Sankyo focused on a key ...

This article and associated images are based on a poster originally authored by Rose Bigley, James Craswell, Michael Carter, Philip Fallon, and Nicholas Bland, and presented at ELRIG Drug Discovery ...

BERNARDSVILLE, N.J., April 10, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven ...

The MarketWatch News Department was not involved in the creation of this content. SEATTLE, April 15, 2025 /PRNewswire/ -- Wayfinder Biosciences, a biotechnology company targeting RNA with small ...

The "RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's offering.